Regeneron Pharmaceuticals (REGN) Posts Q4 Loss of 37c/Share

February 13, 2012 7:01 AM EST
Get Alerts REGN Hot Sheet
Price: $534.27 -0.68%

EPS Growth %: +49.8%

Financial Fact:
Total expenses: 857.32M

Today's EPS Names:
Trade Now! 
Join SI Premium – FREE
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported Q4 EPS of ($0.37), $0.23 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $123 million versus the consensus estimate of $131.04 million.

For earnings history and earnings-related data on Regeneron Pharmaceuticals, Inc. (REGN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities